Immunovant (IMVT) Selling, General & Administrative (2018 - 2026)
Immunovant (IMVT) Selling, General & Administrative (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
-7.36 Mn |
| 10 |
Immunovant |
5.71 Bn |
5.71 Bn |
- |
17.27 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
17.27 Mn |
| Dec 31, 2025 |
15.44 Mn |
| Sep 30, 2025 |
17.51 Mn |
| Jun 30, 2025 |
26.02 Mn |
| Mar 31, 2025 |
20.17 Mn |
| Dec 31, 2024 |
19.78 Mn |
| Sep 30, 2024 |
18.47 Mn |
| Jun 30, 2024 |
18.81 Mn |
| Mar 31, 2024 |
14.82 Mn |
| Dec 31, 2023 |
13.22 Mn |
| Sep 30, 2023 |
13.84 Mn |
| Jun 30, 2023 |
15.40 Mn |
| Mar 31, 2023 |
12.42 Mn |
| Dec 31, 2022 |
11.78 Mn |
| Sep 30, 2022 |
11.88 Mn |
| Jun 30, 2022 |
11.95 Mn |
| Mar 31, 2022 |
15.24 Mn |
| Dec 31, 2021 |
11.52 Mn |
| Sep 30, 2021 |
16.29 Mn |
| Jun 30, 2021 |
11.18 Mn |
